Matches in SemOpenAlex for { <https://semopenalex.org/work/W17013> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W17013 endingPage "95" @default.
- W17013 startingPage "188" @default.
- W17013 abstract "Although factors that appear to predict long-term outcomes of rheumatoid arthritis have been identified, there is no consensus about the treatment early in the disease. To determine how French office- and hospital-based rheumatologists treat early rheumatoid arthritis, we created three clinical vignettes corresponding to different levels of severity of early rheumatoid arthritis (less than six months' disease duration). Cases 1 and 2 were relatively young patients (35 and 50 years), and Case 1 had numerous poor prognosis factors. Case 3 was 80 years of age. Rheumatologists were asked to indicate which medications they would use at presentation and after one year of a favorable or unfavorable course. The study was conducted by questionnaire (response rate, 58%). Of the 185 rheumatologists who completed the questionnaire, 81% were male and 19% female; mean age was 42 +/- 8 years. In Cases 1 and 2, nonsteroidal antiinflammatory drugs were given by 99% of respondents; second-line drugs were prescribed at presentation by 93% of respondents in Case 1 and 86% in Case 2, and methotrexate was more likely to be used in the presence of poor prognosis factors (23% in case 1 and 7% in Case 2). In the event of an unfavorable course after one year, a larger proportion of rheumatologists prescribed glucocorticoid therapy (65% in Case 1 and 20% in Case 2), and there was a shift from conventional to modern second-line drugs, with more widespread use of methotrexate (65% in case 1 and 18% in case 2). In the 80-year-old patient, glucocorticoid therapy was used more often than nonsteroidal antiinflammatory drugs and second-line drugs (gold salts, hydroxychloroquine, sulfasalazine) were prescribed by 40% of rheumatologists at presentation and by 67% after one year of an unfavorable course; in the latter situation, methotrexate was selected in 24% of cases. In contrast to conventional recommendations, many French office- or hospital-based rheumatologists use second-line drugs very early and base their choice of medications on the estimated risk of severe disease and on the age of the patient." @default.
- W17013 created "2016-06-24" @default.
- W17013 creator A5001198256 @default.
- W17013 creator A5008223577 @default.
- W17013 creator A5023297742 @default.
- W17013 creator A5025555489 @default.
- W17013 creator A5046665684 @default.
- W17013 creator A5047791154 @default.
- W17013 creator A5054224437 @default.
- W17013 creator A5055108045 @default.
- W17013 creator A5057763735 @default.
- W17013 creator A5064134354 @default.
- W17013 creator A5068481031 @default.
- W17013 creator A5072596462 @default.
- W17013 creator A5088180174 @default.
- W17013 date "1996-03-01" @default.
- W17013 modified "2023-10-17" @default.
- W17013 title "How do French rheumatologists treat early rheumatoid arthritis?" @default.
- W17013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8731236" @default.
- W17013 hasPublicationYear "1996" @default.
- W17013 type Work @default.
- W17013 sameAs 17013 @default.
- W17013 citedByCount "2" @default.
- W17013 crossrefType "journal-article" @default.
- W17013 hasAuthorship W17013A5001198256 @default.
- W17013 hasAuthorship W17013A5008223577 @default.
- W17013 hasAuthorship W17013A5023297742 @default.
- W17013 hasAuthorship W17013A5025555489 @default.
- W17013 hasAuthorship W17013A5046665684 @default.
- W17013 hasAuthorship W17013A5047791154 @default.
- W17013 hasAuthorship W17013A5054224437 @default.
- W17013 hasAuthorship W17013A5055108045 @default.
- W17013 hasAuthorship W17013A5057763735 @default.
- W17013 hasAuthorship W17013A5064134354 @default.
- W17013 hasAuthorship W17013A5068481031 @default.
- W17013 hasAuthorship W17013A5072596462 @default.
- W17013 hasAuthorship W17013A5088180174 @default.
- W17013 hasConcept C126322002 @default.
- W17013 hasConcept C1862650 @default.
- W17013 hasConcept C198451711 @default.
- W17013 hasConcept C2777077863 @default.
- W17013 hasConcept C2777575956 @default.
- W17013 hasConcept C2778484676 @default.
- W17013 hasConcept C2779134260 @default.
- W17013 hasConcept C2781059491 @default.
- W17013 hasConcept C2908564923 @default.
- W17013 hasConcept C2909063479 @default.
- W17013 hasConcept C71924100 @default.
- W17013 hasConceptScore W17013C126322002 @default.
- W17013 hasConceptScore W17013C1862650 @default.
- W17013 hasConceptScore W17013C198451711 @default.
- W17013 hasConceptScore W17013C2777077863 @default.
- W17013 hasConceptScore W17013C2777575956 @default.
- W17013 hasConceptScore W17013C2778484676 @default.
- W17013 hasConceptScore W17013C2779134260 @default.
- W17013 hasConceptScore W17013C2781059491 @default.
- W17013 hasConceptScore W17013C2908564923 @default.
- W17013 hasConceptScore W17013C2909063479 @default.
- W17013 hasConceptScore W17013C71924100 @default.
- W17013 hasIssue "3" @default.
- W17013 hasLocation W170131 @default.
- W17013 hasOpenAccess W17013 @default.
- W17013 hasPrimaryLocation W170131 @default.
- W17013 hasRelatedWork W109934668 @default.
- W17013 hasRelatedWork W17013 @default.
- W17013 hasRelatedWork W1992818134 @default.
- W17013 hasRelatedWork W1996155052 @default.
- W17013 hasRelatedWork W2066397332 @default.
- W17013 hasRelatedWork W2100078052 @default.
- W17013 hasRelatedWork W2138243862 @default.
- W17013 hasRelatedWork W2158511924 @default.
- W17013 hasRelatedWork W2996380604 @default.
- W17013 hasRelatedWork W3122960217 @default.
- W17013 hasVolume "63" @default.
- W17013 isParatext "false" @default.
- W17013 isRetracted "false" @default.
- W17013 magId "17013" @default.
- W17013 workType "article" @default.